C4 Therapeutics (CCCC) Amortizatization of Intangibles (2020 - 2026)

C4 Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 39.08% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 37.97% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 49.18% from the prior year.
• Amortizatization of Intangibles improved to $1.1 million in Q1 2026 per CCCC's latest filing, from $863000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q2 2024 and bottomed at -$2.4 million in Q4 2023.
• The 5-year median for Amortizatization of Intangibles is $783000.0 (2025), against an average of $524588.2.
• Biggest YoY gain for Amortizatization of Intangibles was 769.66% in 2023; the steepest drop was 697.03% in 2023.
• Year by year, Amortizatization of Intangibles stood at $404000.0 in 2022, then tumbled by 697.03% to -$2.4 million in 2023, then soared by 144.82% to $1.1 million in 2024, then fell by 20.17% to $863000.0 in 2025, then climbed by 26.19% to $1.1 million in 2026.
• Per Business Quant, the three latest CCCC Amortizatization of Intangibles figures stand at $1.1 million (Q1 2026), $863000.0 (Q4 2025), and $515000.0 (Q3 2025).